Consensus on diagnosis and management of Cushing's disease: a guideline update
Cushing's disease requires accurate diagnosis, careful treatment selection, and long-term
management to optimise patient outcomes. The Pituitary Society convened a consensus …
management to optimise patient outcomes. The Pituitary Society convened a consensus …
Diagnosis and treatment of pituitary adenomas: a review
ME Molitch - Jama, 2017 - jamanetwork.com
Importance Pituitary adenomas may hypersecrete hormones or cause mass effects.
Therefore, early diagnosis and treatment are important. Observations Prevalence of pituitary …
Therefore, early diagnosis and treatment are important. Observations Prevalence of pituitary …
The treatment of Cushing's disease
R Pivonello, M De Leo, A Cozzolino… - Endocrine …, 2015 - academic.oup.com
Abstract Cushing's disease (CD), or pituitary-dependent Cushing's syndrome, is a severe
endocrine disease caused by a corticotroph pituitary tumor and associated with increased …
endocrine disease caused by a corticotroph pituitary tumor and associated with increased …
Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis
F Roelfsema, NR Biermasz, AM Pereira - Pituitary, 2012 - Springer
To study the currently available data of recurrence rates of functioning and nonfunctioning
pituitary adenomas following surgical cure and to analyze associated predisposing factors …
pituitary adenomas following surgical cure and to analyze associated predisposing factors …
Cushing's disease: pathobiology, diagnosis, and management
Cushing's disease (CD) is the result of excess secretion of adrenocorticotropic hormone
(ACTH) by a benign monoclonal pituitary adenoma. The excessive secretion of ACTH …
(ACTH) by a benign monoclonal pituitary adenoma. The excessive secretion of ACTH …
Ketoconazole in Cushing's disease: is it worth a try?
F Castinetti, L Guignat, P Giraud… - The Journal of …, 2014 - academic.oup.com
Background: The use of ketoconazole has been recently questioned after warnings from the
European Medicine Agencies and the Food and Drug Administration due to potential …
European Medicine Agencies and the Food and Drug Administration due to potential …
MANAGEMENT OF ENDOCRINE DISEASE: The burden of Cushing's disease: clinical and health-related quality of life aspects
RA Feelders, SJ Pulgar, A Kempel… - European journal of …, 2012 - academic.oup.com
Objective Cushing's disease (CD) is a rare endocrine disorder characterized by excess
secretion of ACTH due to a pituitary adenoma. Current treatment options are limited and …
secretion of ACTH due to a pituitary adenoma. Current treatment options are limited and …
The gene of the ubiquitin-specific protease 8 is frequently mutated in adenomas causing Cushing's disease
LG Perez-Rivas, M Theodoropoulou… - The Journal of …, 2015 - academic.oup.com
Context: We have recently reported somatic mutations in the ubiquitin-specific protease
USP8 gene in a small series of adenomas of patients with Cushing's disease. Objective: To …
USP8 gene in a small series of adenomas of patients with Cushing's disease. Objective: To …
Outcome of bilateral adrenalectomy in Cushing's syndrome: a systematic review
K Ritzel, F Beuschlein, A Mickisch… - The Journal of …, 2013 - academic.oup.com
Background: The outcome of bilateral adrenalectomy (BADx) in patients with Cushing's
syndrome (CS) is not well characterized. Methods: A literature search was performed with …
syndrome (CS) is not well characterized. Methods: A literature search was performed with …
Epidemiology of Cushing's syndrome
C Steffensen, AM Bak, K Zøylner Rubeck… - …, 2010 - karger.com
Overt Cushing's syndrome is a rare disorder with an annual incidence of 2–3/million of
which benign adrenal adenomas account for 0.6/million. The female: male ratio is 3: 1 …
which benign adrenal adenomas account for 0.6/million. The female: male ratio is 3: 1 …